Enrolling By Invitation PHASE1 INTERVENTIONAL 1-arm
NCT07228702
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection: An Open Label Individual Patient Study
Sponsor: Vancouver Coastal Health
Interventions
Amikacin Injection Bedaquiline (B) Clofazimine Linezolid (LZD) Mycobacteriophage Muddy_HRMN0052 Sulfamethoxazole/Trimethoprim
Updated 1 time since 2025 Last updated: Nov 13, 2025 Started: Nov 30, 2025 Primary completion: Oct 31, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Mycobacterium Abscessus Infection and Non-Tuberculous Mycobacterial (NTM) Pneumonia, this trial is ongoing. The trial is conducted by Vancouver Coastal Health and has accumulated 1 data snapshot since 2025. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Enrolling By Invitation — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Vancouver Coastal Health
Data source: Vancouver Coastal Health
For direct contact, visit the study record on ClinicalTrials.gov .